Medicine
New Targets Bring Promise For Lung Cancer Therapy
Egbert Smit
EGBERT SMIT, Free University of Amsterdam
There are a number of promising new molecular targets for lung cancer chemotherapy which were discussed at the Turin congress by Egbert Smit. He talked with Peter Goodwin about insulin-like growth factor inhibitors, heat shock protein and an inhibitor of angiogenesis involving the c-MET protein.
There are a number of promising new molecular targets for lung cancer chemotherapy which were discussed at the Turin congress by Egbert Smit. He talked with Peter Goodwin about insulin-like growth factor inhibitors, heat shock protein and an inhibitor of angiogenesis involving the c-MET protein.
Similar Interviews
Bivalirudin For Angioplasty: Expensive Heparin?»
Tony Gershlick, University of Leicester
Adnan Kastrati, Deutsches Herzzentrum, Munich
Using bivalirudin instead of heparin during angioplasty wasn't any better for preventing death, MI or urgent revascularisation in the 4,500-patient ISAR-REACT 3 study presented at the ACC annual meeting. Tony Gershlick and Adnan Kastrati discuss the study with Peter Goodwin and Sarah Freeman.Tony Gershlick, University of Leicester
Adnan Kastrati, Deutsches Herzzentrum, Munich
Tropical Health Research: London Scientist Honored»
Brian Greenwood, London School of Hygiene and Tropical Medicine
Brian Greenwood, of the London School of Hygiene and Tropical Medicine, has won the Hideyo Noguchi Africa Prize for his numerous achievements in tropical disease research. He talked withy Derek Thorne about his work, including the pivotal research proving that bed nets can help prevent malaria.Brian Greenwood, London School of Hygiene and Tropical Medicine
© 2008 Audio Medica - Medical Audio News Interviews & Podcasts. 
Post a comment